DeGraw et al.
13.6; 31P NMR (CDCl3, 121 MHz) δ 31.8; IR (NaCl, cm-1) ν 3400
(br), 2955 (m), 1719 (m), 1683 (m). HRMS (ESI) calcd for
C12H24O4P [M + H]+ 263.1412; found 263.1419.
2925 (w), 1715 (m), 1655 (m), 1101 (m). HRMS (ESI) calcd for
C24H27O9P2 [M - H]- 521.1136; found 521.1174. The ammonium
counterions within this compound are not observed during mass
spectral analysis.
Dimethyl (E,E)-((8-(3-Benzoyl)benzoyloxy)-3,7-dimethylocta-
2,6-dienyl)phosphonate (11). To a solution of 10 (2.2 g, 8.3 mmol)
and 3-benzoyl benzoic acid (2.3 g, 10 mmol) in anhydrous CH2Cl2
(100 mL) were added DCC (2.1 g, 10 mmol) and DMAP (50 mg,
0.40 mmol) at rt. The resulting suspension was stirred for 20 h at
room temperature and then filtered through Celite. The filtrate was
concentrated and chromatographed on silica gel (hexanes/ethyl
acetate, 2:1 to 1:2) to give the ester as a viscous oil (3.3 g, 82%):
1H NMR (CDCl3, 300 MHz) δ 8.43 (1H, m), 8.24 (1H, dt, J )
7.8, 1.8 Hz), 7.97 (1H, dt, J ) 7.8, 1.5 Hz), 7.79 (1H, m), 7.77
(1H, m), 7.45-7.62 (4H, m), 5.50 (1H, m), 5.17 (1H, m), 4.70
(2H, s), 3.72 (3H, s), 3.69 (3H, s), 2.55 (2H, dd, J ) 7.8, 21.9 Hz),
2.16 (2H, m), 2.09 (2H, m), 1.70 (3H, s), 1.65 (3H, d, J ) 3.3 Hz);
13C NMR (CDCl3, 75 MHz) δ 195.8, 165.6, 139.9 (d, J ) 14.3
Hz), 137.9, 137.0, 134.0, 133.2, 132.8, 131.0, 130.6, 130.1, 130.0,
129.4, 128.5, 128.4, 112.5 (d, J ) 11.1 Hz), 70.9, 52.6, 52.5, 38.9
(d, J ) 2.6 Hz), 26.1 (d, J ) 3.4 Hz), 25.4 (d, J ) 140.0 Hz), 16.2
(d, J ) 2.4 Hz), 14.0; 31P NMR (CDCl3, 121 MHz) δ 31.6; IR
(NaCl, cm-1) ν 3065 (w), 2955 (s), 2854 (m), 1731 (s), 16675 (s)
1602 (s), 1579 (m). HRMS (ESI) calcd for C26H32O6P [M + H]+
471.1936; found 471.1945.
Ammonium (E,E)-8-(3-Benzoylbenzoyloxy)-3,7-dimethylocta-
2,6-dienylphosphonate (12). To a solution of 11 (1.0 g, 2.1 mmol)
in anhydrous CH2Cl2 (30 mL) were added allyltrimethylsilane (0.50
mL, 3.1 mmol) and bromotrimethylsilane (0.90 mL, 6.8 mmol) at
rt. The mixture was stirred for 38 h and concentrated in vacuo.
The residue was dissolved in H2O (4.0 mL), neutralized with NH4-
HCO3, then lyophilized to afford the phosphonic acid in its
ammonium form as a white powder (0.87 g, 92%): 1H NMR (25
mM NaHCO3 in D2O, 500 MHz) δ 7.80 (1H, s), 7.60 (1H, s), 7.27
(1H, d, J ) 6.0 Hz), 7.15 (2H, m), 7.00 (2H, m), 6.89 (2H, m),
5.06 (1H, s), 5.01 (1H, d, J ) 5.5 Hz), 4.15 (2H, s), 2.10 (2H, d,
J ) 15.0 Hz), 1.67 (4H, m), 1.28 (3H, s), 1.17 (3H, s); 13C NMR
(25 mM NaHCO3 in D2O, 75 MHz) δ 195.1, 165.3, 136.8, 136.4
(d, J ) 13.0 Hz), 136.0, 133.8, 132.7, 129.9, 129.8, 129.6, 129.2,
128.1, 117.1, 70.9, 38.6, 28.9 (d, J ) 131.2 Hz), 25.9, 15.3, 13.2;
31P NMR (25 mM NaHCO3 in D2O, 121 MHz) δ 22.8. IR (NaCl,
cm-1) ν 2971 (w), 2922 (w), 1720 (s), 1655 (s), 1602 (w). HRMS
(ESI) calcd for C24H26O6P [M - H]- 441.1473; found 441.1481.
The ammonium counterions within this compound are not observed
during mass spectral analysis.
(E,E)-â-P-(3-Benzoylbenzoyloxy)-3,7-dimethylocta-2,6-di-
enylphosphonophosphate ([32P]-3b). A mixture of phosphonate
1 (4.0 mg, 8.0 µmol) and 1,1′-carbonyldiimidazole (4.0 mg, 24
µmol) in anhydrous DMF (250 µL) was stirred for 12 h at rt. 32P-
Labeled phosphoric acid was then prepared by lyophilizing 250
µL of 1% (v/v) phosphoric acid and 250 µL of 10 mCi/mL 32P-
phosphoric acid over P2O5 overnight. Activated phosphonate in
DMF was then added via syringe to the flask containing the dry
32P-labeled phosphoric acid (4.0 mg, 40 µmol), left to stir for 24 h
at rt, and monitored by TLC (6:3:1 2-propanol/NH4OH/H2O).
Solvent was then removed under a stream of N2(g). The residue
was dissolved in 25 mM NH4HCO3 (3 mL) and applied to a Sep-
Pak column equilibrated in the same solution. The column was
washed with a step gradient of 25 mM NH4HCO3 and increasing
CH3CN (10% increase per step, 2 mL per step). Fractions were
collected and analyzed by TLC (6:3:1 2-propanol/NH4OH/H2O).
Under these conditions, the desired product 2 eluted at 30-40%
CH3CN/25 mM NH4HCO3. Product fractions were pooled, lyoph-
ilized, and dissolved in 1.0 mL of 25 mM NH4HCO3. UV analysis
(ꢀ258 24 100 mol-1 cm-1) and liquid scintillation counting were used
to determine the solution concentration and specific activity (0.55
mM and 334 Ci/mol). The solution was used for protein cross-
linking experiments without further purification.
Acid Stability Study of GPP. Five hundred microliters of a 1.0
mM solution of GPP in 50:50 25 mM NH4HCO3/CH3CN containing
0.2% TFA was allowed to sit at rt. Fifty microliter aliquots were
removed at prescribed intervals (h) and analyzed by reverse-phase
HPLC. A gradient of solvent A (25 mM NH4HCO3) and solvent B
(CH3CN) and detecting at 214 nm (flow rate, 0.7 mL/min) was
employed. Elution was performed by a 40 min linear gradient of
20-80% B. Integration of the peak corresponding to GPP was
performed using HPLC software. Hydrolysis half-life was deter-
mined from a plot of remaining starting material (%) as a function
of time.
Acid Stability Study of 3b. The same procedure as described
for GPP was performed with a 0.30 mM solution of 3b in 50:50
25 mM NH4HCO3/CH3CN containing 0.2% TFA.
Purification of yPFTase and hPGGTase-I. yPFTase was
purified as described by Mayer et al.41 and published in our earlier
work.16 hPGGTase-I was purified using modifications of published
procedures.12,42,43
Ammonium (E,E)-P-8-(3-Benzoylbenzoyloxy)-3,7-dimethyl-
octa-2,6-dienylphosphonophosphate (3b). A mixture of the phos-
phonate 12 (100 mg, 230 µmol) and 1,1′-carbonyldiimidazole (60
mg, 370 µmol) in anhydrous DMF (4.0 mL) was stirred for 5 h at
rt. To this clear solution was added directly 98% phosphoric acid
solid (∼50 mg, 510 µmol). The solvent was removed under high
vacuum after being stirred for 27 h. The residue was dissolved in
H2O (1.0 mL) and loaded on an octyl-functionalized silica gel
column (18 cm × 1 cm). The column was washed with a step
gradient of H2O and MeOH (10 mL per step, 10% MeOH per step)
from 0 to 70% MeOH. Fractions were collected, and those
containing product as determined by TLC were pooled and
lyophilized. The lyophilized powder was dissolved in H2O, passed
through a short, strong acidic ion exchange column, then washed
with H2O. The resulting solution was neutralized with NH4HCO3
and lyophilized to give the product in its ammonium form as a
white powder (28 mg, 23%): 1H NMR (D2O, 300 MHz) δ 7.77
(1H, s), 7.75 (1H, d, J ) 7.5 Hz), 7.50 (1H, d, J ) 7.5 Hz), 7.09-
7.31 (6H, m), 5.16 (1H, m), 5.03 (1H, m), 4.26 (2H, s), 2.33 (2H,
dd, J ) 7.5, 21.5 Hz), 1.78 (4H, m), 1.39 (3H, d, J ) 3.3 Hz), 1.31
(3H, s); 13C NMR (D2O, 75 MHz) δ 197.5, 166.4, 138.2 (d, J )
14.0 Hz), 136.6, 135.7, 134.3, 133.4, 130.6, 129.8, 129.5, 129.4,
128.7, 128.4, 115.5 (d, J ) 9.7 Hz), 71.1, 38.5, 28.4 (d, J ) 135.2
Hz), 25.7, 15.4, 13.1; 31P NMR (D2O, 121 MHz, pD 7.0, NH4+) δ
16.4 (d, J ) 26.4 Hz), -9.6 (d, J ) 26.4 Hz); IR (NaCl, cm-1) ν
Enzyme Assays. A continuous fluorescence assay was employed
to monitor yPFTase activity as described by Gaon et al.16 modified
from the original published procedures.44,45
Enzyme Inhibition Experiments. The concentration of 3b was
varied (0, 0.4, 0.6, 1.5, 3, 4.5, 6 µM), while the natural substrate,
1, and yPFTase were maintained at a fixed concentrations (10 µM
and 11 nM). Enzymatic rates were obtained from linear regression
analysis of the time-dependent fluorescence emission data using
the fluorimeter software, and the IC50 was calculated from a plot
of the enzymatic rate versus concentration of 3b.
X-ray Crystallography Studies. Crystals of the rPFTase:3b
complex were prepared by soaking 3b into preformed crystals using
methods previously described.32 X-ray diffraction data for the
PFTase:3b complex were collected on a Rigaku rotating anode
(41) Mayer, M. P.; Prestwich, G. D.; Dolence, J. M.; Bond, P. D.; Wu,
H. Y.; Poulter, C. D. Gene 1993, 132, 41-47.
(42) Stirtan, W. G.; Poulter, C. D. Arch. Biochem. Biophys. 1995, 321,
182-190.
(43) Zhang, F. L.; Diehl, R. E.; Kohl, N. E.; Gibbs, J. B.; Giros, B.;
Casey, P. J.; Omer, C. A. J. Biol. Chem. 1994, 269, 3175-3180.
(44) Cassidy, P. B.; Dolence, J. M.; Poulter, C. D. Methods Enzymol.
1995, 250, 30-43.
(45) Pompliano, D. L.; Gomez, R. P.; Anthony, N. J. J. Am. Chem. Soc.
1992, 114, 7945-7946.
4594 J. Org. Chem., Vol. 72, No. 13, 2007